9-134883353-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004108.3(FCN2):āc.266A>Gā(p.Asn89Ser) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,613,358 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004108.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCN2 | NM_004108.3 | c.266A>G | p.Asn89Ser | missense_variant, splice_region_variant | 3/8 | ENST00000291744.11 | NP_004099.2 | |
FCN2 | NM_015837.3 | c.152A>G | p.Asn51Ser | missense_variant, splice_region_variant | 2/7 | NP_056652.1 | ||
FCN2 | XM_011518392.4 | c.233A>G | p.Asn78Ser | missense_variant, splice_region_variant | 3/8 | XP_011516694.1 | ||
FCN2 | XM_006717015.5 | c.119A>G | p.Asn40Ser | missense_variant, splice_region_variant | 2/7 | XP_006717078.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCN2 | ENST00000291744.11 | c.266A>G | p.Asn89Ser | missense_variant, splice_region_variant | 3/8 | 1 | NM_004108.3 | ENSP00000291744.6 | ||
FCN2 | ENST00000350339.3 | c.152A>G | p.Asn51Ser | missense_variant, splice_region_variant | 2/7 | 5 | ENSP00000291741.5 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152108Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250672Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135654
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1461132Hom.: 0 Cov.: 33 AF XY: 0.00000963 AC XY: 7AN XY: 726914
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152226Hom.: 0 Cov.: 31 AF XY: 0.0000941 AC XY: 7AN XY: 74416
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 19, 2022 | The c.266A>G (p.N89S) alteration is located in exon 3 (coding exon 3) of the FCN2 gene. This alteration results from a A to G substitution at nucleotide position 266, causing the asparagine (N) at amino acid position 89 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at